BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 53 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | +16.7% | 5,903 | -7.2% | 0.00% | – |
| Q3 2019 | $6,000 | +50.0% | 6,360 | +295.0% | 0.00% | – |
| Q2 2019 | $4,000 | -20.0% | 1,610 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 1,610 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -54.5% | 1,610 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | +120.0% | 1,610 | +163.9% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 610 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 610 | +19.6% | 0.00% | – |
| Q4 2017 | $4,000 | -42.9% | 510 | -14.4% | 0.00% | – |
| Q3 2017 | $7,000 | +16.7% | 596 | +20.2% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 496 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -33.3% | 496 | -9.0% | 0.00% | – |
| Q4 2016 | $9,000 | -18.2% | 545 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | +120.0% | 545 | +32.9% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 410 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | – | 410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |